consult a health-care practitioner before use if you have a liver or kidney disease or if you have been instructed to follow a low-protein diet
Food and Drug Administration, but some doctors prescribe the medication "off-label" for weight loss, as is permissible Wegovy and Zepbound, which contain the same active ingredients as Ozempic and Mounjaro, respectively, are each FDA-approved as a weight loss management treatment for people with obesity, or those who are overweight with at least one related underlying condition, such as high blood pressure
Appetite suppression GLP-1 medications reduce appetite, which helps you eat less
Contact your insurance provider and ask about the coverage details for semaglutide, including any co-pays or out-of-pocket costs you might incur
And that distinction matters
You can read their full statement, below